Literature DB >> 23813926

Severe infantile leigh syndrome associated with a rare mitochondrial ND6 mutation, m.14487T>C.

Mark Tarnopolsky1, Brandon Meaney, Brian Robinson, Katherine Sheldon, Richard G Boles.   

Abstract

We describe a case of severe infantile-onset complex I deficiency in association with an apparent de novo near-homoplasmic mutation (m.14487T>C) in the mitochondrial ND6 gene, which was previously associated with Leigh syndrome and other neurological disorders. The mutation was near-homoplasmic in muscle by NextGen sequencing (99.4% mutant), homoplasmic in muscle by Sanger sequencing, and it was associated with a severe complex I deficiency in both muscle and fibroblasts. This supports previous data regarding Leigh syndrome being on the severe end of a phenotypic spectrum including progressive myoclonic epilepsy, childhood-onset dystonia, bilateral striatal necrosis, and optic atrophy, depending on the proportion of mutant heteroplasmy. While the mother in all previously reported cases was heteroplasmic, the mother and brother of this case were homoplasmic for the wild-type, m.14487T. Importantly, the current data demonstrate the potential for cases of mutations that were previously reported to be homoplasmic by Sanger sequencing to be less homoplasmic by NextGen sequencing. This case underscores the importance of considering mitochondrial DNA mutations in families with a negative family history, even in offspring of those who have tested negative for a specific mtDNA mutation.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Leigh disease; deep sequencing; homoplasmy; mitochondrial disease

Mesh:

Substances:

Year:  2013        PMID: 23813926     DOI: 10.1002/ajmg.a.36000

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

1.  Mitochondrial DNA mutation 14487T>C manifesting as Leber's hereditary optic neuropathy.

Authors:  M Eckenweiler; C B Catarino; C Gallenmueller; T Klopstock; W A Lagrèze; R Korinthenberg; J Kirschner
Journal:  J Neurol       Date:  2015-11-03       Impact factor: 4.849

Review 2.  The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease.

Authors:  Martin P Horan; David N Cooper
Journal:  Hum Genet       Date:  2013-12-04       Impact factor: 4.132

3.  Contribution of the MRPS22 variant and a Down mosaic to the phenotype.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Metab Brain Dis       Date:  2017-09-30       Impact factor: 3.584

4.  Mutation-specific effects in germline transmission of pathogenic mtDNA variants.

Authors:  Auke B C Otten; Suzanne C E H Sallevelt; Phillippa J Carling; Joseph C F M Dreesen; Marion Drüsedau; Sabine Spierts; Aimee D C Paulussen; Christine E M de Die-Smulders; Mary Herbert; Patrick F Chinnery; David C Samuels; Patrick Lindsey; Hubert J M Smeets
Journal:  Hum Reprod       Date:  2018-07-01       Impact factor: 6.918

5.  Rapid identification of a novel complex I MT-ND3 m.10134C>A mutation in a Leigh syndrome patient.

Authors:  David K Miller; Minal J Menezes; Cas Simons; Lisa G Riley; Sandra T Cooper; Sean M Grimmond; David R Thorburn; John Christodoulou; Ryan J Taft
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

6.  Expanded genetic codes in next generation sequencing enable decontamination and mitochondrial enrichment.

Authors:  Kevin J McKernan; Jessica Spangler; Lei Zhang; Vasisht Tadigotla; Stephen McLaughlin; Jason Warner; Amir Zare; Richard G Boles
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

7.  Bilateral striatal necrosis due to homoplasmic mitochondrial 3697G>A mutation presents with incomplete penetrance and sex bias.

Authors:  Shanshan Zhong; Shumeng Wen; Yusen Qiu; Yanyan Yu; Ling Xin; Yang He; Xuguang Gao; Hezhi Fang; Daojun Hong; Jun Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-01-08       Impact factor: 2.183

8.  De novo mtDNA point mutations are common and have a low recurrence risk.

Authors:  Suzanne C E H Sallevelt; Christine E M de Die-Smulders; Alexandra T M Hendrickx; Debby M E I Hellebrekers; Irenaeus F M de Coo; Charlotte L Alston; Charlotte Knowles; Robert W Taylor; Robert McFarland; Hubert J M Smeets
Journal:  J Med Genet       Date:  2016-07-22       Impact factor: 6.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.